ERYTECH PHARMA - SPON ADR (ERYP)

US29604W1080 - ADR

0.78  0 (0%)

Full profile views are only available for registered users, you can see which data is available below.

Examples of complete profiles are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional data.

ERYTECH PHARMA - SPON ADR

NASDAQ:ERYP (6/28/2023, 7:00:02 PM)

0.78

0 (0%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Overview
Earnings (Last)
Earnings (Next)
Ins Owners
Inst Owners
Market Cap26.61M
Shares
PEN/A
Fwd PEN/A
Dividend YieldN/A
Analysts
IPO
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

ERYP Daily chart

Company Profile

ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The company is headquartered in Lyon, Auvergne-Rhone-Alpes and currently employs 49 full-time employees. The company went IPO on 2013-05-07. The firm offers ESY-ASP (GRASPA), a medicinal product consisting of L-Asparaginase entrapped into human homologous red blood cells. The product is used for treatment of Acute Lymphoblastic Leukemia (ALL), a childhood cancer. The firm's technology is based on the use of human red blood cells (RBCs) to improve the pharmacokinetic (PK) and pharmacodynamic (PD) properties of therapeutic enzymes, for instance asparaginase. The enzyme can destroy asparagine and deprive cancer cells of an important nutrient for these cells, resulting in their death.

Company Info

ERYTECH PHARMA - SPON ADR

60 avenue Rockefeller, Batiment Adenine

Lyon AUVERGNE-RHONE-ALPES 69008

P: 33478744438.0

CEO: Gil Beyen

Employees: 49

Website: https://erytech.com/

ERYP News

News Imagea year ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

It's time for another dive into the biggest pre-market stock movers traders need to know about as we cover the winners and losers for Friday!

News Imagea year ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time for another dive into the biggest pre-market stock movers as we check out the latest news traders need to know about on Thursday!

News Imagea year ago - InvestorPlaceWhy Is Lexaria Bioscience (LEXX) Stock Down 27% Today?

Lexaria Bioscience (LEXX) stock is falling on Tuesday after the company revealed details about its public share offering.

News Imagea year ago - InvestorPlaceWhy Is Ohmyhome (OMH) Stock Down 31% Today?

Ohmyhome (OMH) stock is taking a beating on Tuesday but it's not due to any recent news concerning the property management company.

News Imagea year ago - InvestorPlaceWhy Is Palantir (PLTR) Stock Up 16% Today?

Palantir (PLTR) stock is on the rise Tuesday morning after the company posted earnings for the first quarter of the year!

News Imagea year ago - InvestorPlaceWhy Is Erytech Pharma (ERYP) Stock Up 47% Today?

Erytech Pharma (ERYP) stock is on the rise Tuesday after the company provided investors with a business update for the first quarter of 2023!

ERYP Twits

Here you can normally see the latest stock twits on ERYP, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example